GHX CEO Bruce Johnson introduces a new five-part video series in which he will share insights and observations crowdsourced from one of the largest healthcare communities in the industry. Tune in to celebrate healthcare community triumphs and learn how you can strengthen the healthcare supply chain and minimize financial risk during times of crisis.
Episode 5: Building a Stronger, More Resilient Healthcare Supply Chain
In the final video in the series, Bruce reflects on the impact COVID-19 has had on the healthcare industry, discusses areas that are ripe for evolution and offers suggested next steps.
To the members of the GHX community who are working tirelessly to fight COVID-19:
This is a time of great uncertainty for us all. But we recognize there is even greater pressure on our healthcare providers and suppliers to have answers.
Patients are looking to caregivers to allay the fear their symptoms might be the coronavirus, for definitive diagnosis and a treatment path and how long it will take to fully recover. In turn, providers are looking to manufacturers who can reliably supply the critical medical equipment they desperately need – in the required quantity, in the shortest timeframe possible.
This dynamic ignited GHX to action. We created the COVID-19 Information Center to deliver the insights, data and tools to help our community tackle the pressing challenges of securing supplies, identifying clinically comparable product alternatives and setting up overflow care facilities. Our goal is to empower you to respond to the call for answers.
When GHX was founded 20 years ago there wasn’t a road map, but over time we collectively built an amazing community. This unprecedented time calls on us to re-imagine what healthcare's 'new normal' looks like and we will build a stronger future together.
- Bruce Johnson
Bruce Johnson Video Series (do we have a formal title?)
footer - we can add a button here
To the members of the GHX community who are working tirelessly to fight COVID-19:
This is a time of great uncertainty for us all. But we recognize there is even greater pressure on our healthcare providers and suppliers to have answers.
Patients are looking to caregivers to allay the fear their symptoms might be the coronavirus, for definitive diagnosis and a treatment path and how long it will take to fully recover. In turn, providers are looking to manufacturers who can reliably supply the critical medical equipment they desperately need – in the required quantity, in the shortest timeframe possible.
This dynamic ignited GHX to action. We created the COVID-19 Information Center to deliver the insights, data and tools to help our community tackle the pressing challenges of securing supplies, identifying clinically comparable product alternatives and setting up overflow care facilities. Our goal is to empower you to respond to the call for answers.
When GHX was founded 20 years ago there wasn’t a road map, but over time we collectively built an amazing community. This unprecedented time calls on us to re-imagine what healthcare's 'new normal' looks like and we will build a stronger future together.
In response to COVID-19, GHX is committed to helping ensure that our customers receive access to the data and information needed to help maintain critical supplies to serve patients and protect staff.
We understand that inventory availability may be limited for specific medical product categories, resulting in a need to find alternative sources.
In order to support the healthcare community with these alternative source research efforts, GHX referenced McKinsey’s report, COVID-19 Crisis: US Healthcare Provider and Payer Preparedness a list of anticipated medical product shortages. Key data teams at both GHX and Lumere have identified multiple manufacturers and distributors that supply the items referenced in the McKinsey report and provided the following resources:
Reference list of vendors for critical supplies at risk of shortages, by product category. - DOWNLOAD NOW
Complimentary access is currently available through April 2020 to the Lumere evidence-based research on drugs and devices, including a quick reference list of COVID-19 related supplies with potential shortages.
